isospaglumic acid has been researched along with Dementia Praecox in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, PB; Brandt, AS; Churchill, G; Edden, RA; Harris, AD; Hua, J; Lim, IA; Margolis, RL; Pradhan, S; Ross, CA; Unschuld, PG; van Zijl, PC | 1 |
| Baslow, MH | 2 |
| Ende, G; Hoerst, M; Meyer-Lindenberg, A; Tunc-Skarka, N; Weber-Fahr, W; Zink, M | 1 |
| Bubeníková-Valešová, V; Franěk, M; Rokyta, R; Šťastný, F; Vaculín, S; Yamamotová, A | 1 |
| Reynolds, GP; Reynolds, LM | 1 |
| Fujita, Y; Hashimoto, K; Slusher, BS; Takatsu, Y; Tsukamoto, T | 1 |
| Bzdega, T; Janczura, KJ; Lavin, KM; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP; Zuo, D | 1 |
| Block, W; Fingerhut, N; Jessen, F; Kühn, KU; Maier, W; Petrovsky, N; Schild, HH; Sprinkart, AM; Träber, F; Wagner, M | 1 |
| Bergeron, R; Coyle, JT | 1 |
| Barker, PB; Edden, RA; Holcomb, HH; Kontson, K; Rowland, LM; West, J; Wijtenburg, SA; Zhu, H | 1 |
| Nudmamud, S; Reynolds, GP; Reynolds, LM | 1 |
| Colvin, SM; Coyle, JT; Ghose, S; Herman, MM; Hyde, TM; Kleinman, JE; Weickert, CS | 1 |
| Tsai, SJ | 2 |
| Bzdega, T; Gehl, LM; Neale, JH; Olszewski, RT; Wroblewska, B | 1 |
| Wroblewska, B | 1 |
| Baer, L; Carter, R; Coyle, JT; Kleinman, JE; Passani, LA; Slusher, BS; Tsai, G | 1 |
| Coyle, JT | 1 |
| Baer, L; Chang, RW; Coyle, JT; Flood, J; Goff, DC; Tsai, G | 1 |
7 review(s) available for isospaglumic acid and Dementia Praecox
| Article | Year |
|---|---|
The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Astrocytes; Dipeptides; Glutamate Carboxypeptidase II; Humans; Neuroprotective Agents; Receptors, Metabotropic Glutamate; Schizophrenia | 2008 |
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
Topics: Animals; Astrocytes; Brain Injuries; Dipeptides; Glutamate Carboxypeptidase II; Humans; Hyperalgesia; Neuralgia; Neuropeptides; Neurotransmitter Agents; Peripheral Nervous System Diseases; Protease Inhibitors; Schizophrenia; Substance-Related Disorders | 2011 |
NAAG, NMDA receptor and psychosis.
Topics: Animals; Dipeptides; Glutamate Carboxypeptidase II; Hippocampus; Humans; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2012 |
The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Ischemia; Diabetic Neuropathies; Dipeptides; Glutamate Carboxypeptidase II; Humans; Pain; Protease Inhibitors; Schizophrenia | 2005 |
Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.
Topics: Animals; Aspartic Acid; Brain; Dipeptides; Glutamic Acid; Humans; Models, Neurological; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2005 |
NAAG as a neurotransmitter.
Topics: Animals; Brain Chemistry; Dipeptides; Neurotransmitter Agents; Pain; Schizophrenia | 2006 |
The nagging question of the function of N-acetylaspartylglutamate.
Topics: Animals; Brain; Carboxypeptidases; Dipeptides; Epilepsy; Humans; Isoenzymes; Schizophrenia; Tissue Distribution | 1997 |
13 other study(ies) available for isospaglumic acid and Dementia Praecox
| Article | Year |
|---|---|
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
Topics: Adult; Aging; Antipsychotic Agents; Aspartic Acid; Choline; Creatine; Dipeptides; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Gyrus Cinguli; Humans; Inositol; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia | 2016 |
Is the tri-cellular N-acetylaspartylglutamate (NAAG) cycle related to the etiology of schizophrenia?
Topics: Dipeptides; Humans; Schizophrenia | 2016 |
MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.
Topics: Adult; Analysis of Variance; Aspartic Acid; Creatine; Dipeptides; Female; Frontal Lobe; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nerve Fibers, Myelinated; Phosphocreatine; Protons; Schizophrenia; Water | 2009 |
Pain perception in neurodevelopmental animal models of schizophrenia.
Topics: Age Factors; Animals; Animals, Newborn; Dipeptides; Disease Models, Animal; Female; Hot Temperature; Humans; Injections, Intraventricular; Male; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Physical Stimulation; Proto-Oncogene Proteins c-fos; Quinolinic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2010 |
Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
Topics: Adult; Aspartic Acid; Bipolar Disorder; Brain; Depressive Disorder, Major; Dipeptides; Female; Humans; Male; Middle Aged; Schizophrenia | 2011 |
Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
Topics: Administration, Oral; Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds; Dipeptides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Glutarates; Male; Mice; Neural Inhibition; Schizophrenia; Sensory Gating; Sulfhydryl Compounds; Xanthenes | 2011 |
N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.
Topics: Adult; Aspartic Acid; Dipeptides; Female; Functional Laterality; Humans; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Prefrontal Cortex; Protons; Psychiatric Status Rating Scales; Schizophrenia | 2013 |
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia.
Topics: Adult; Age Factors; Attention; Cerebrum; Dipeptides; Female; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Schizophrenia; Severity of Illness Index; Young Adult | 2013 |
N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
Topics: Aspartic Acid; Autopsy; Biomarkers; Bipolar Disorder; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder; Dipeptides; Frontal Lobe; Humans; Schizophrenia; Temporal Lobe | 2003 |
Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Autoradiography; Binding Sites; Carboxypeptidases; Chlorpromazine; Cohort Studies; Dipeptides; DNA, Complementary; Female; Frontal Lobe; Gene Expression; Haplorhini; Hippocampus; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Male; Middle Aged; Neural Networks, Computer; Neuroglia; Neurotoxins; RNA, Messenger; Schizophrenia; Silver Staining; Temporal Lobe | 2004 |
Strategies to increase central N-acetyl aspartylglutamate: a potential treatment for schizophrenia and bipolar disorders.
Topics: Bipolar Disorder; Dipeptides; Humans; Neuroprotective Agents; Schizophrenia | 2005 |
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
Topics: Adult; Aged; Antigens, Surface; Brain; Dipeptidases; Dipeptides; Female; Glutamate Carboxypeptidase II; Glutamates; Hippocampus; Humans; Male; Middle Aged; Prefrontal Cortex; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 1995 |
Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Biomarkers; Corpus Striatum; Dipeptides; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Glutamates; Humans; Lipid Peroxides; Male; Middle Aged; Neuropeptides; Oxidative Stress; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Superoxide Dismutase; Synaptic Transmission | 1998 |